FDA Ultrasound Guidance Removes 510(k) Special Report Recommendation
This article was originally published in The Gray Sheet
Executive Summary
An ultrasound manufacturer no longer needs to submit a "510(k) special report" prior to shipping a new device as long as it keeps appropriate records in its design history file, according to an FDA 1guidance issued Sept. 9
You may also be interested in...
Current Fetal Ultrasound Practices Could Increase Risks, Studies Suggest
A sharp increase in the use of fetal ultrasounds in recent years in women with healthy pregnancies from an average of 2 scans to 5 scans per pregnancy and recent warnings from medical societies could prompt FDA to look more closely at possible risks to the fetus from ultrasound.
DIAGNOSTIC ULTRASOUND 510(k)S COULD INCLUDE THIRD-PARTY CERTIFICATION IN LIEU OF CERTAIN SAFETY DATA, FDA SAYS IN DRAFT REVISED GUIDANCE DOCUMENT
Manufacturers of diagnostic ultrasound systems could submit third-party certification of compliance to certain voluntary standards in 510(k)s instead of submitting actual performance data covered by the standards under draft revisions to FDA's guidance document for diagnostic ultrasound systems and transducers.
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.